SevenBridge Financial Group’s Kairos Pharma KAPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,327
Closed -$17.1K – 219
2026
Q2
$17.1K Hold
6,327
– – ﹤0.01% 212
2026
Q1
$30.3K Hold
6,327
– – ﹤0.01% 202
2025
Q4
$31.9K Hold
6,327
– – 0.01% 207
2025
Q3
$37.7K Hold
6,327
– – 0.01% 210
2025
Q2
$49.6K Hold
6,327
– – 0.01% 217
2025
Q1
$28.3K Buy
+6,327
New +$56.7K 0.01% 220

Other funds holding KAPA

SevenBridge Financial Group's KAPA Position: Q3 2026 in Review

SevenBridge Financial Group sold out of Kairos Pharma (KAPA) in Q3 2026, closing a stake of 6,327 shares — an estimated $17.1K sold.

SevenBridge Financial Group first reported a position in KAPA in Q1 2025 and held it in 6 quarters. The position peaked at $49.6K in Q2 2025. 5 funds tracked by Wall St. Rank hold KAPA as of Q3 2026.

  • SevenBridge Financial Group reported no remaining Kairos Pharma position as of Q3 2026 after selling out during the quarter.
  • SevenBridge Financial Group sold 6,327 Kairos Pharma shares in Q3 2026, an estimated $17.1K.
  • SevenBridge Financial Group first reported a position in Kairos Pharma in Q1 2025 and held it in 6 quarters.
  • SevenBridge Financial Group's Kairos Pharma position peaked at $49.6K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Kairos Pharma as of Q3 2026.

Based on SevenBridge Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.